4th Quarter - Termination

CROSSROADS STRATEGIES, LLC for ECOLAB, INC.

Firm
Client
Income
$20,000
Expenses
—
Terminated
Nov 17, 2015

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Food and Drug Administration (FDA) related issues including the Antiseptic Handwash Rule.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Pesticide Registration Improvement Extension Act Reauthorization issues

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Clean Air and Water (quality) CAW

H.R.2898, Western Water and American Food Security Act of 2015. H.R.2028/Senate, Energy and Water Development and Related Agencies Appropriations Act, 2016. Water infrastructure issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2028 (114th), H.R. 2898 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.